
- Accepting New Patients
- Telehealth Visits
- Insurance plan information

Karen Zhang, MD
Family Medicine- Accepting New Patients
- Telehealth Visits
- Insurance plan information



Karen Zhang, MD
Family Medicine- Accepting New Patients
- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Family Medicine, American Board of Family Medicine
Residency
- Family Medicine, UCSF Graduate Medical Education
My expertise
Specialties
- Family Medicine
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%224061%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%224061%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Showing 1-6 of 58 reviews
- February 14, 20265 out of 5 Stars
The service was more than Good it was Great. I got more out of the visit than I expected. I'm pleased, and impress with the service. UCSF is getting is Grove back, I love this facility.
- February 12, 20265 out of 5 Stars
Dr. K. Zhang was amazing. She understood my problem and thought outside of box. She found a treatment that actually helped. It's a lucky patient that gets her at urgent care.
- February 8, 20265 out of 5 Stars
Karen was so nice. She was easy to talk to and sympathetic to my condition. I felt very taken care of.
- February 4, 20265 out of 5 Stars
Discussed everything in detail, involved me in decision making
- January 17, 20265 out of 5 Stars
Dr. Zhang is the best. Listens, knows all questions and routines to test (competent and thorough), friendly as could be. Followed up labs she ordered to call and say all negative for stroke. Who does that anymore?! Privilege to meet her.
- January 13, 20265 out of 5 Stars
Nice job very happy
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.